zenix sec-150 column (Sepax Inc)
90
Structured Review
Sepax Inc
zenix sec-150 column
Zenix Sec 150 Column, supplied by Sepax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zenix+sec-150+column/zenix+sec+300+column/pmc12008586-161-7-10
Average 90 stars, based on 1 article reviews
Zenix Sec 150 Column, supplied by Sepax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zenix+sec-150+column/zenix+sec+300+column/pmc12008586-161-7-10
Average 90 stars, based on 1 article reviews
zenix sec-150 column - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Degradable Hydrogel for Sustained Localized Delivery of Anti-Tumor Drugs. Article Snippet: HPLC-SEC analysis was performed on an Agilent 1260 system using a Zenix Article Title: Splicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe disease Article Snippet: For SEC-HPLC, compounds were analyzed on a Zenix Article Title: Splicing correction by peptide-conjugated morpholinos as a novel treatment for Late-Onset Pompe Disease Article Snippet: For SEC-HPLC, compounds were analyzed on a Zenix Article Title: Structural insights into the disulfide isomerase and chaperone activity of TrbB of the F plasmid type IV secretion system Article Snippet: TrbB WT , TrbB 37-161 , His 6 TraW, and His 6 ΔTraW at 19 μM in 20 mM Article Title: Covalent Binding Mechanism of Furmonertinib and Osimertinib With Human Serum Albumin. Article Snippet: As third-generation tyrosine kinase inhibitors, furmonertinib and osimertinib exhibit better efficacy than firstand second-generation tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.. However, radioactive pharmacokinetics studies showed that parent-related components remain in human plasma for at least 21 days after oral administration.. Similar pharmacokinetic profiles were found in pyrotinib and neratinib, which have been identified to covalently bind with human serum albumin at Lys-190, leading to low extraction recovery in protein precipitation. |